Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 27:7:41518.
doi: 10.1038/srep41518.

Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013

Affiliations

Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013

Jing Wu et al. Sci Rep. .

Abstract

Obesity and obesity-related diseases are important public health challenges. In this study, we aimed to provide updated trends in the prevalence of these conditions. We conducted two independent cross-sectional surveys of the general population aged 20-75 years in 2007 and 2013 in Jilin, China. A total of 3636 (1719 males) and 1359 (602 males) participants were enrolled in the 2007 and 2013 surveys, respectively. Obesity-related diseases were defined as type 2 diabetes, hypertension, dyslipidemia and non-alcoholic fatty liver disease (NAFLD). The age-standardized prevalence of obesity, overweight, diabetes, pre-diabetes, dyslipidemia and NAFLD increased from 2007 to 2013 from 15.82% to 19.41%, 35.85% to 41.80%, 6.37% to 9.23%, 16.77% to 23.49%., 53.46% to 65.50%, and 23.48% to 44.31% in males, respectively, and from 13.18% to 18.77%, 31.11% to 37.54%, 4.41% to 8.48%, 8.10% to 16.49%, 41.96% to 54.70%, and 17.56% to 43.06% in females, respectively. However, the prevalence of hypertension remained stable (males: 38.10% vs. 38.63% and females: 33.04% vs. 33.01% in 2007 and 2013, respectively). The prevalence of obesity and obesity-related diseases, except for hypertension, increased significantly in the general population in Northeastern China. More targeted measures should be implemented to address the serious challenges presented by these diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1. The prevalence of obesity and obesity-related diseases in different age groups.
NAFLD, non-alcoholic fatty liver diseases; (A) Obesity prevalence; (B) Diabetes prevalence; (C) Hypertension prevalence; (D) Dyslipidemia prevalence; (E) NAFLD prevalence. The black line means 2013 years; the grey line means 2007 years; The triangle blot means males while the square blot means females.

References

    1. Ng M. et al.. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 384, 766–781 (2014). - PMC - PubMed
    1. Shi X. D. et al.. Prevalence of obesity and associated risk factors in northeastern China. Diabet. Res. Clin. Pract. 91, 389–394 (2011). - PubMed
    1. Kelly T., Yang W., Chen C. S., Reynolds K. & He J. Global burden of obesity in 2005 and projections to 2030. Int. J. Obes. (Lond.). 32, 1431–1437 (2008). - PubMed
    1. Lim S. S. et al.. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380, 2224–2260 (2012). - PMC - PubMed
    1. Dixon J. B. The effect of obesity on health outcomes. Mol. Cell. Endocrinol. 316, 104–108 (2010). - PubMed

Publication types